Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 3
449
Views
4
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Plasma and hepatic concentrations of acetaminophen and its primary conjugates after oral administrations determined in experimental animals and humans and extrapolated by pharmacokinetic modeling

, , ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 316-323 | Received 20 Oct 2020, Accepted 05 Nov 2020, Published online: 19 Nov 2020

References

  • Behrends, V., et al. 2019. Acetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolism. Archives of toxicology, 93 (2), 341–353.
  • Bessems, J.G. and Vermeulen, N.P., 2001. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Critical reviews in toxicology, 31 (1), 55–138.
  • Cyranoski, D., 2014. Marmosets are stars of Japan’s ambitious brain project. Nature, 514 (7521), 151–152.
  • Dargue, R., et al. 2020. Metabolism and effects on endogenous metabolism of paracetamol (acetaminophen) in a porcine model of liver failure. Toxicological sciences, 175 (1), 87–97.
  • Hasegawa, M., et al. 2011. The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional. Biochemical and biophysical research communications, 405 (3), 405–410.
  • Henderson, C.J., et al. 2000. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proceedings of the National Academy of Sciences of the United States of America, 97 (23), 12741–12745.
  • Jaeschke, H., Xie, Y., and McGill, M.R., 2014. Acetaminophen-induced liver injury: from animal models to humans. Journal of clinical and translational hepatology, 2 (3), 153–161.
  • Kamiya, Y., et al. 2019. Plasma and hepatic concentrations of chemicals after virtual oral administrations extrapolated using rat plasma data and simple physiologically based pharmacokinetic models. Chemical research in toxicology, 32 (1), 211–218.
  • Kamiya, Y., et al. 2020. Physiologically based pharmacokinetic models predicting renal and hepatic concentrations of industrial chemicals after virtual oral doses in rats. Chemical research in toxicology, 33 (7), 1736–1751.
  • Laine, J.E., et al. 2009. Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica; the fate of foreign compounds in biological systems, 39 (1), 11–21.
  • Lee, K.C., et al. 2013. A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival. Liver international, 33 (4), 544–551.
  • McGill, M.R. and Jaeschke, H., 2019. Animal models of drug-induced liver injury. Biochimica et biophysica acta. Molecular basis of disease, 1865 (5), 1031–1039.
  • McGill, M.R., et al. 2012. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicology and applied pharmacology, 264 (3), 387–394.
  • McGill, M.R., et al. 2011. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology, 53 (3), 974–982.
  • Miura, T., et al. 2019. Human plasma and liver concentrations of styrene estimated by combining a simple physiologically based pharmacokinetic model with rodent data. The journal of toxicological sciences, 44 (8), 543–548.
  • Mogi, M., et al. 2012. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs. The journal of toxicological sciences, 37 (6), 1157–1164.
  • Neirinckx, E., et al. 2010. Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen. Research in veterinary science, 89 (1), 113–119.
  • Ogawa, S.I., et al. 2020. Increased plasma concentrations of an antidyslipidemic drug pemafibrate co-administered with rifampicin or cyclosporine A in cynomolgus monkeys genotyped for the organic anion transporting polypeptide 1B1. Drug metabolism and pharmacokinetics, 35 (4), 354–360.
  • Rollins, D.E., et al. 1979. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science, 205 (4413), 1414–1416.
  • Sakamoto, Y., et al. 2016. Comparative pharmacokinetic study of acetaminophen in Japanese and Han Chinese individulals. Japanese journal of clinical pharmacology and therapeutics, 47 (1), 11–16.
  • Shida, S., et al. 2015. Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling. Xenobiotica; the fate of foreign compounds in biological systems, 45 (10), 881–886.
  • Shida, S. and Yamazaki, H., 2016. Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling. Xenobiotica; the fate of foreign compounds in biological systems, 46 (9), 759–764.
  • Takano, R., et al. 2010. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling. Regulatory toxicology and pharmacology, 58 (2), 252–258.
  • Toda, A., et al. 2018. Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19. Xenobiotica; the fate of foreign compounds in biological systems, 48 (7), 720–726.
  • Uchimura, T., et al. 2010. Prediction of human blood-to-plasma drug concentration ratio. Biopharmaceutics and drug disposition, 31, 286–297.
  • Utoh, M., et al. 2016. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling. Xenobiotica; the fate of foreign compounds in biological systems, 46 (12), 1049–1055.
  • Yamazaki, H., et al. 2016. Combining chimeric mice with humanized liver, mass spectrometry, and physiologically-based pharmacokinetic modeling in toxicology. Chemical research in toxicology, 29 (12), 1903–1911.
  • Yu, H., et al. 2015. Metabolism by conjugation appears to confer resistance to paracetamol (acetaminophen) hepatotoxicity in the cynomolgus monkey. Xenobiotica; the fate of foreign compounds in biological systems, 45 (3), 270–277.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.